Formulary Search Results for: CALCIUM AND VITAMIN D
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
The use for the treatment of HIV-1 infection in treatment naive adults, or treatment experienced adults without known mutations associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, tenofovir or emtricitabine, and with viral load ≤100,000 HIV-1 RNA copies/mL, is restricted to HIV specialists only.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
Use in the treatment of HIV infection is restricted to use by HIV specialists only.
Use for the pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk men who have sex with men, including adolescents (with body weight at least 35 kg) is restricted to specialist use for those patients who have renal or bone issues for whom other alternative PrEP options are not suitable.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC is generic Emtricitabine/tenofovir disoproxil.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
- The treatment of HIV infection is restricted to use by HIV specialists.
- Use in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk is restricted to specialist use only by consultants in sexual health and infectious disease consultants.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC.
Non-Formulary indications:
- Treatment of HIV-1 infected adolescents aged 12 to <18 years with nucleoside reverse transcriptase inhibitor resistance or toxicities precluding the use of first-line agents
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
Restricted to specialist use for the treatment of relapsing remitting multiple sclerosis in accordance with local guidelines.
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
The treatment of adult patients with relapsing remitting multiple sclerosis is restricted to specialist use in accordance with local guidelines.
12.1.2 Otitis media - View Category
Restrictions:
Restricted to use in the treatment of acute otitis media in patients with tympanostomy tubes (AOMT).